Repeated analysis in second human cancer cell line, A549, uncovers cell type specific responses, with 2 out the 6 sites studied (CA9 and FGF11 promoters) only displaying accessibility sensitivity to hypoxia in HeLa cells. This evidence concerns the gene FGF11 and cancer.